TBRA

Tobira Therapeutics, Inc. Common Stock
TBRA

Delisted

TBRA was delisted on the 31st of October, 2016.

15 hedge funds and large institutions have $10.9M invested in Tobira Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
15
Holders Change
Holders Change %
0%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BI
1
BVF Inc
California
$7.91M 1,659,091
WC
2
Wexford Capital
Florida
$1.55M 324,177 -32,214 -9%
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$553K 116,017 +50,000 +76%
Deutsche Bank
4
Deutsche Bank
Germany
$229K 48,272 +21,089 +78%
Goldman Sachs
5
Goldman Sachs
New York
$226K 47,289 +20,199 +75%
Morgan Stanley
6
Morgan Stanley
New York
$153K 32,020 -44,808 -58%
SIM
7
Spark Investment Management
New York
$77K 16,200 -12,500 -44%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$72K 15,222
VKH
9
Virtu KCG Holdings
New York
$66K 13,722 -9,603 -41%
Vanguard Group
10
Vanguard Group
Pennsylvania
$53K 11,200 +11,200 New
TRCT
11
Tower Research Capital (TRC)
New York
$17K 3,620 +2,258 +166%
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$10K 2,000 +2,000 New
U
13
UBS
Switzerland
$7K 1,564 +1,110 +244%
Bank of America
14
Bank of America
North Carolina
$5K 1,084 -4,128 -79%
OIA
15
Optimum Investment Advisors
Illinois
$5K 1,000
Jane Street
16
Jane Street
New York
-14,598 Closed
Citigroup
17
Citigroup
New York
-1,220 Closed